Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.38
Price to sales ratio
18.82

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3722
ADAG
Adagene Inc - ADS, each representing 1.25
3.69 USD-3.40%-5.14%+1.93%+92.19%174.85 M USD
3735
TLSA
Tiziana Life Sciences Ltd - Common Shares
1.43 USD+7.52%+15.32%+23.28%-2.05%172.33 M USD
3749
ALEC
Alector, Inc. - Common Stock
1.48 USD-1.99%-22.92%-5.13%-12.43%164.32 M USD
3752
ANTX
AN2 Therapeutics, Inc. - Common Stock
4.73 USD+3.96%+7.74%-0.21%+337.96%170.36 M USD

Frequently asked questions about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

What is the Corbus Pharmaceuticals Holdings, Inc. - Common Stock stock price today?

The current price of Corbus Pharmaceuticals Holdings, Inc. - Common Stock (CRBP) is 9.2. Over the past 24 hours, the stock has changed by +1.77%. Follow the CRBP chart for real-time price dynamics.

What is the stock ticker of Corbus Pharmaceuticals Holdings, Inc. - Common Stock?

Corbus Pharmaceuticals Holdings, Inc. - Common Stock trades under the ticker CRBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Corbus Pharmaceuticals Holdings, Inc. - Common Stock stock going up?

CRBP has changed by -2.85% over the last week, +10.71% over the last month, and -44.58% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Corbus Pharmaceuticals Holdings, Inc. - Common Stock net income for the last quarter?

Corbus Pharmaceuticals Holdings, Inc. - Common Stock reported net income of -22.97 M for the last quarter. The previous quarter showed -20.55 M, which means net income changed by -11.74%.

How many employees does Corbus Pharmaceuticals Holdings, Inc. - Common Stock have?

As of the latest available data, Corbus Pharmaceuticals Holdings, Inc. - Common Stock has 36 employees. Workforce size can provide additional context about the company's scale and operations.

What is Corbus Pharmaceuticals Holdings, Inc. - Common Stock EBITDA?

Corbus Pharmaceuticals Holdings, Inc. - Common Stock EBITDA is -22.94 M, and its EBITDA margin is -1 740.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Corbus Pharmaceuticals Holdings, Inc. - Common Stock stock?

You can buy Corbus Pharmaceuticals Holdings, Inc. - Common Stock (CRBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Corbus Pharmaceuticals Holdings, Inc. - Common Stock stock?

Investing in Corbus Pharmaceuticals Holdings, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRBP chart and related analysis on metatrader.com as part of your research.

News